• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION OBTRYX II SYSTEM - CURVED; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION OBTRYX II SYSTEM - CURVED; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR Back to Search Results
Model Number 850-411
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Erosion (1750); Headache (1880); Incontinence (1928); Pain (1994); Abnormal Vaginal Discharge (2123); Anxiety (2328); Depression (2361); Constipation (3274); Dyspareunia (4505); Insufficient Information (4580)
Event Date 01/31/2017
Event Type  Injury  
Event Description
It was reported to boston scientific corporation that an obtryx ii sling was implanted into the patient on (b)(6) 2016.The patient experienced complications, further surgery, and nonsurgical treatment.Patient symptoms include: eep (erosion/extrusion/protrusion of the mesh); back pain; vaginal pain; pelvic pain; groin pain; perineum pain; anal pain; rectal pain; thigh pain; other pain: like getting stabbed with a hot poker in abdomen & thighs; painful intercourse; inability to have intercourse; offensive vaginal discharge; difficulties with bowel motions; incontinence not present before implant; recurrent incontinence; aggravated incontinence; damage; psychiatric injury.Surgical interventions: - on (b)(6) 2019 the patient underwent further surgery regarding the obtryx ii implant under general anesthesia for the following purpose: cystoscopy, laparoscopy & bilateral salpingectomy.- on (b)(6) 2021 the patient underwent further surgery regarding the obtryx ii implant under general anesthesia for the following purpose: excision of vaginal mesh, cystoscopy & eua.- on (b)(6) 2021 the patient underwent further surgery regarding the obtryx ii implant under general anesthesia for the following purpose: excision of vaginal mesh & cystoscopy.Nonsurgical treatments: - on (b)(6) 2016 the patient commenced pain medication: ovestin cream, anpec for cluster headaches due to stress, vesicare, escitalopram for anxiety, neo mercazole for overactive thyroid.For the treatment of: infections, cluster headaches, anxiety, incontinence, overactive thyroid.Treatment duration: 5.- on (b)(6) 2018 the patient commenced incontinence medication: vesicare 5mg for the treatment of: for incontinence.Treatment duration: 4.- the patient was treated with psychological medication.On (b)(6) 2017 the patient commenced other medication (please specify): escitalopram 20mg for the treatment of: anxiety & depression.Treatment duration: 4.- on (b)(6) 2019 the patient commenced topical treatment (including oestrogen cream): ovestin for the treatment of: continual disgusting discharge & to help with repair before & after surgeries.Treatment duration: 3.- the patient was treated with other (not specified).- on (b)(6) 2017 the patient commenced pain medication: panadin forte for the treatment of: abdominal pain & cluster headaches.Treatment duration: 4.
 
Manufacturer Narrative
(b)(6) the complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.The upn provided was chosen as a representative upn to capture the implanted device.The complainant indicated that the device is not available for return; therefore, a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OBTRYX II SYSTEM - CURVED
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC, FOR STRESS URINARY INCONTINENCE, RETR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
780 brookside drive
spencer IN 47460
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key12929723
MDR Text Key286448233
Report Number3005099803-2021-07149
Device Sequence Number1
Product Code OTN
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K121754
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 12/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number850-411
Device Catalogue Number850-411
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/10/2021
Initial Date FDA Received12/03/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age48 YR
Patient SexFemale
Patient Weight64 KG
-
-